INPP5D and Alzheimer disease: Although there was no evidence for risk in PCA vs controls, the risk effects at rs35349669 in INPP5D (P = .02, PGC = .02) and rs2718058 upstream of NME8 (P = .03, PGC = .04) both were nominally different in PCA than typical AD.